As we peer into the not-too-distant future, is it possible that some of the treatments that seem so innovative today will also be looked back upon as unsophisticated?
From a bi-weekly newsletter to an award-winning quarterly magazine, BioSupply Trends Quarterly has grown to be a timely, trustworthy source for biopharmaceutical news.
Dr. Craig Kessler has been a specialist in acquired hemophilia since the late 1980s.
As CEO of FFF Enterprises, Inc., Patrick Schmidt takes pride in his company’s success in helping to secure the specialty biopharmaceuticals marketplace over the past 26 years.
When Alice Dunkley was diagnosed with inherited chronic obstructive pulmonary disease (COPD), she was given less than five years to live. Twenty-six years later, this active grandmother continues to beat the odds.
Dr. Barbara P. Yawn shares Important aspects of testing, therapies and exacerbations of COPD that every primary care physician should know.
A deeper look at major risks in the healthcare industry, including lack of preventative care, inadequate care, adverse drug reactions and counterfeit drugs.
As U.S. Director of Sales & Marketing, Influenza, Chris Woolway is creating strategic partnerships to address industry challenges.
Dr. Jacob Teitelbaum, a specialist in chronic fatigue syndrome and fibromyalgia, uses a holistic approach to treating fibromyalgia called S.H.I.N.E.
Diagnosed in 2004 with fibromyalgia, Linda Thornrose is always in pain and deals with chronic insomnia. What she wishes most is that people would understand that this is a real disease and offer some kindness.
Dr. Marc Riedl has specialized in treating primary immune deficiency patients for more than 12 years.
Just as it was impossible for previous generations to predict today’s scientific and technological advances, we are similarly challenged when looking to the future. But the path to progress begins with innovation.
